Academic Journal
Q1Lancet Gastroenterology and Hepatology
About Lancet Gastroenterology and Hepatology
Lancet Gastroenterology and Hepatology is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 13.113 and an H-index of 141.
Its listed coverage is 2016-2026 and its research categories include Gastroenterology (Q1); Hepatology (Q1). The 2025 dataset reports 217 documents and 9364 citations across the latest three-year reporting window.
Lancet Gastroenterology and Hepatology is one of the most prestigious peer-reviewed medical journals dedicated to advancing research in the fields of gastroenterology and hepatology. As part of The Lancet family, this journal provides a platform for groundbreaking studies, clinical trials, and expert reviews that contribute to the understanding and treatment of digestive diseases and liver disorders.
Why Lancet Gastroenterology and Hepatology Matters
With an increasing global burden of gastrointestinal and liver diseases, high-quality research is crucial to improving patient care. Lancet Gastroenterology and Hepatology publishes innovative research that helps clinicians, researchers, and healthcare policymakers make informed decisions.Key Areas of Focus
The journal covers a broad spectrum of topics, including:- Gastrointestinal Disorders: Research on conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and colorectal cancer.
- Liver Diseases: Studies on hepatitis, cirrhosis, fatty liver disease (NAFLD/NASH), and liver transplantation.
- Endoscopy and Imaging: Advancements in diagnostic techniques and minimally invasive procedures.
- Microbiome Research: Exploring the role of gut microbiota in digestive health.
- Clinical Trials and Therapies: Evaluating the latest treatments and medical interventions.
Impact Factor and Reputation
Lancet Gastroenterology and Hepatology boasts a high impact factor, reflecting its influence in the medical research community. It is widely cited by clinicians and researchers, making it a trusted source for the latest advancements in digestive and liver health.Benefits for Researchers and Clinicians
Publishing in Lancet Gastroenterology and Hepatology provides researchers with global visibility and credibility. Clinicians benefit from up-to-date knowledge that enhances their ability to diagnose and treat patients effectively.SEO-Friendly Aspects of This Content
To optimize this article for search engines, we have incorporated relevant keywords such as:- Lancet Gastroenterology and Hepatology journal
- Gastrointestinal diseases research
- Liver disease studies
- Impact factor of Lancet Gastroenterology
- Gastroenterology clinical trials
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Lancet Gastroenterology & Hepatology is a prestigious, peer-reviewed medical journal dedicated to the latest advancements in gastroenterology, hepatology, and pancreatology. Published by The Lancet, one of the most respected medical publishers globally, the journal provides high-impact research, reviews, and opinion pieces that shape the field.
Key Areas of Focus
The journal covers a wide range of topics related to digestive health, including:- Gastroenterology: Research on gastrointestinal disorders, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and colorectal cancer.
- Hepatology: Studies on liver diseases such as hepatitis, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and liver transplantation.
- Pancreatology: Insights into pancreatic disorders, including pancreatitis and pancreatic cancer.
- Endoscopy & Imaging: Advanced diagnostic techniques for digestive system diseases.
- Clinical Trials & Therapeutics: The latest drug developments and treatment strategies for gastrointestinal and liver conditions.
- Epidemiology & Public Health: Population-based studies and preventive measures for digestive diseases.
Why is The Lancet Gastroenterology & Hepatology Important?
- High-Impact Research: The journal publishes groundbreaking studies that contribute to medical advancements in digestive health.
- Global Collaboration: It features research from experts worldwide, ensuring a diverse and comprehensive perspective.
- Clinical Relevance: The content is tailored for healthcare professionals, helping them stay updated with the latest treatment guidelines and clinical practices.
- Innovation in Medicine: The journal highlights cutting-edge diagnostic tools and therapies that improve patient care.
- Open Discussions & Opinions: Editorials and commentaries provide expert insights into emerging trends and debates in the field.
SEO Keywords for Better Visibility
To improve online visibility, content about The Lancet Gastroenterology & Hepatology should include keywords like:- Gastroenterology research journal
- Hepatology medical journal
- Liver disease studies
- Digestive health research
- Clinical trials in gastroenterology
- Endoscopy advancements
- Gastrointestinal disorders journal
- Hepatitis research articles
Recent Research Articles
Latest publications matched automatically by ISSN.
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial
Mazen Noureddin, Winston Dunn, Rashmee Patil, Dimple Desai et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00130-5Liver stiffness dynamics in European populations – Authors’ reply
Jesse Pustjens, Pere Ginès, Willem Pieter Brouwer
2026-10 · DOI: 10.1016/s2468-1253(26)00238-4From viral clearance to cancer prevention: the next phase of hepatitis elimination
Mohamed AbdAllah, Wael Abdel-Razek, Mohamed Hassany
2026-10 · DOI: 10.1016/s2468-1253(26)00236-0Bowel endometriosis: from pathogenesis to clinical management
Fabio Barra, Edoardo Giovanni Giannini, Maria Grazia Centurioni, Claudio Gustavino et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00117-2Cyclosporiasis and CDC cuts: the perfect storm
The Lancet Gastroenterology & Hepatology
2026-10 · DOI: 10.1016/s2468-1253(26)00245-1Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial
Robert Hüneburg, Querijn N E van Bokhorst, Maria Pellisé, Francesc Balaguer et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00163-9A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study
Alessandro Mannucci, Caiming Xu, Francesc Balaguer, Yoshinaga Okugawa et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00180-9Correction to Lancet Gastroenterol Hepatol 2026; published online July 16. https://doi.org/10.1016/S2468-1253(26)00163-9
2026-10 · DOI: 10.1016/s2468-1253(26)00235-9Prevention of colorectal cancer through screening for advanced precancerous lesions: are blood-based tests the answer?
Jean M Winter, Erin L Symonds
2026-10 · DOI: 10.1016/s2468-1253(26)00197-4WHO global hepatitis report 2026: guiding global action for elimination
Olufunmilayo Lesi, Diana Faini, Irwin Law, Mathieu Bastard et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00220-7Propelling MASLD trials into the era of non-invasive tests
Li-You Lian, Wen-Yue Liu, Wenhao Li, Rohit Loomba et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00153-6Launch of the Africa CDC toolkit for hepatitis B: bringing care closer to people in Africa
Alexander J Stockdale, Gibril Ndow, Danjuma Adda, Sangwoo Tak et al.
2026-10 · DOI: 10.1016/s2468-1253(26)00221-9Correction to Lancet Gastroenterol Hepatol 2026; 11: 627–44
2026-10 · DOI: 10.1016/s2468-1253(26)00246-3Barrier restoration as a therapeutic strategy for disorders of gut–brain interaction
Timmie A Britton, Madhusudan Grover
2026-10 · DOI: 10.1016/s2468-1253(26)00081-6Liver stiffness dynamics in European populations
Stéphanie André-Dumont, Nicolas Lanthier
2026-10 · DOI: 10.1016/s2468-1253(26)00188-3Blood-based CRC screening: closer, but not there yet
The Lancet Gastroenterology & Hepatology
2026-10 · DOI: 10.1016/s2468-1253(26)00244-xCombination therapy in metabolic dysfunction-associated steatohepatitis
Oren Shibolet, Helena Katchman
2026-09 · DOI: 10.1016/s2468-1253(26)00151-2The central role of primary care in liver health
Rob Brierley, Hugh Thomas
2026-09 · DOI: 10.1016/s2468-1253(26)00196-2Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis – Authors' reply
Rajiv Jalan, Vishal C Patel, Saeed Shoaie
2026-09 · DOI: 10.1016/s2468-1253(26)00191-3Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
Walter Reinisch, David Stepek, Radoslaw Kempinski, Silvio Danese et al.
2026-09 · DOI: 10.1016/s2468-1253(26)00120-2Reviews
Community Reviews
Version History
April 16, 2025 at 11:07 am
April 3, 2025